Barriers to new drug development in respiratory disease

Eur Respir J. 2015 May;45(5):1197-207. doi: 10.1183/09031936.00007915.

¹ Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK p.j.barnes@imperial.ac.uk.
² Second University of Naples, Caserta, Italy Institute of Translational Pharmacology-CNR, Rome, Italy European Medicines Agency, London, UK.
³ University of Giessen and Marburg Lung Centre, Member of the German Centre for Lung Research (DZL), Giessen, Germany.
⁴ Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK.
⁵ European Affairs Dept, European Respiratory Society, Brussels, Belgium.
⁶ National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, UK.

No abstract available

Publication types